Johan Harmenberg

2.5k citations

81 papers · 1.9k indexed · h-index 24

Impact in

Virology top 5%
- HIV Research and Treatment
Hematology top 5%
- Multiple Myeloma Research and Treatments

Papers in ⓘ

Virology 12
- HIV Research and Treatment 11
Hematology 20
- Multiple Myeloma Research and Treatments 19

Co-authors: Britta Wahrén (20 shared papers)Stig Åkerfeldt (2 shared papers)Gustav Gilljam (3 shared papers)Spotswood L. Spruance (3 shared papers)Anna Karlsson (3 shared papers)B. Öberg (2 shared papers)Lars Franzén (1 shared paper)K. Pigott (1 shared paper)
Journals: Antimicrobial Agents and Chemotherapy (12 papers)Blood (9 papers)Antiviral chemistry & chemotherapy (6 papers)Journal of Clinical Oncology (4 papers)Antiviral Research (3 papers)
Partner nations: Sweden United States Italy

In The Last Decade

Johan Harmenberg

79 papers receiving 1.7k citations

Peers

Countries citing papers authored by Johan Harmenberg

Since Specialization

Citations

This map shows the geographic impact of Johan Harmenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Harmenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Harmenberg more than expected).

Fields of papers citing papers by Johan Harmenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Harmenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Harmenberg. The network helps show where Johan Harmenberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Johan Harmenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johan Harmenberg Line = papers co-authored together Johan Harmenberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study The Lancet Oncology ·Sten Nilsson, Lars Franzén, Christopher Parker, Christopher Tyrrell, René Blom, Jan Tennvall, Bo Lennernäs, Ulf Petersson, Dag Clement Johannessen, M. Sokal, K. Pigott, Jeffrey Yachnin, Michael Garkavij, Peter Strang, Johan Harmenberg, B. Bolstad, Øyvind S. Bruland	2007	354
2	The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline Antiviral Research ·Johan Harmenberg, Annelie Åkesson-Johansson, Astrid Gräslund, Torbjörn Malmfors, Jan Bergman, Britta Wahrén, Stig Åkerfeldt, Leif Lundblad, Susan Cox	1991	85
3	Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs Antimicrobial Agents and Chemotherapy ·Johan Harmenberg, Britta Wahrén, J. BERGMAN, Stig Åkerfeldt, Leif Lundblad	1988	74
4	Melflufen - a peptidase-potentiated alkylating agent in clinical trials Oncotarget ·Malin Wickström, Peter Nygren, Rolf Larsson, Johan Harmenberg, Jakob Lindberg, Per J. R. Sjöberg, Markus Jerling, Fredrik Lehmann, Paul G. Richardson, Kenneth C. Anderson, Dharminder Chauhan, Joachim Gullbo	2017	67
5	Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study The Lancet Haematology ·Paul G. Richardson, Sara Bringhen, Peter M. Voorhees, Torben Plesner, Ulf-Henrik Mellqvist, Brandi Reeves, Claudia E. Paba‐Prada, Hanan Zubair, Catriona Byrne, Dharminder Chauhan, Kenneth C. Anderson, Eva Nordström, Johan Harmenberg, Antonio Palumbo, Pieter Sonneveld	2020	62
6	Influence of Cells and Virus Multiplicity on the Inhibition of Herpesviruses with Acycloguanosine Intervirology ·Johan Harmenberg, Britta Wahrén, Bo Ouml berg	1980	53
7	Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet Antimicrobial Agents and Chemotherapy ·Rie Koshida, Lotta Vrang, Gustav Gilljam, Johan Harmenberg, B. Öberg, Britta Wahrén	1989	51
8	Double-Blind, Randomized, Placebo-Controlled Study of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of UV Radiation-Induced Herpes Labialis Antimicrobial Agents and Chemotherapy ·Thomas G. Evans, David I. Bernstein, G. Wayne Raborn, Johan Harmenberg, Jan Kowalski, Spotswood L. Spruance	2002	49
9	Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1 Antimicrobial Agents and Chemotherapy ·Rie Koshida, S. Cox, Johan Harmenberg, Gustav Gilljam, Britta Wahrén	1989	44
10	Comparison of Different Tests of Fencing Performance International Journal of Sports Medicine ·Johan Harmenberg, Roberta Ceci, P. Barvestad, K. Hjerpe, J. Scott Nystrom	1991	43
11	Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma Acta Oncologica ·Simon Ekman, Jan‐Erik Frödin, Johan Harmenberg, Antonina Bergman, Åsa Hedlund, Pia Dahg, Carina Alvfors, Birgitta Ståhl, Stefan Bergström, Michael Bergqvist	2010	41
12	Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity Journal of Clinical Virology ·Mehrdad Mousavi‐Jazi, Lottie Schloss, William Drew, Annika Linde, Richard C. Miner, Johan Harmenberg, Britta Wahrén, Maria Brytting	2001	41
13	G‐ and GM‐CSF in oncology and oncological haematology European Journal Of Haematology ·Johan Harmenberg, Martin Höglund, Eva Hellström‐Lindberg	1994	39
14	Herpes simplex virus type 1 infection and glucocorticoid treatment regulate viral yield, glucocorticoid receptor and NF-kappaB levels Journal of Endocrinology ·A. Erlandsson, LG Bladh, Pontus Stierna, Tülay Yucel‐Lindberg, Ola Hammarsten, Thomas Modéer, Johan Harmenberg, A-C Wikström	2002	39
15	Prevention of Ulcerative Lesions by Episodic Treatment of Recurrent Herpes Labialis: A Literature Review Acta Dermato Venereologica ·Johan Harmenberg, B. Öberg, Spotswood L. Spruance	2010	37
16	Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds Antimicrobial Agents and Chemotherapy ·A Akesson-Johansson, Johan Harmenberg, Britta Wahrén, Annika Linde	1990	37
17	Physiological and Morphological Characteristics of World Class Fencers International Journal of Sports Medicine ·Jessica Nyström, O. Lindwall, Ruggero Ceci, Johan Harmenberg, J. Swedenhag, Björn Ekblom	1990	34
18	A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds Journal of Virological Methods ·Britta Wahrén, Johan Harmenberg, V A Sundqvist, B Levén, Birgit Sköldenberg	1983	32
19	Intracellular Pools of Thymidine Reduce the Antiviral Action of Acyclovir Intervirology ·Johan Harmenberg	1983	27
20	Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract Urological Research ·Kiyoshi Koshida, Johan Harmenberg, U Stendahl, B. Wahren, E. Borgstr�m, L. Helstr�m, L. Andersson	1985	26

About Johan Harmenberg

Johan Harmenberg is a scholar working on Virology, Hematology, Epidemiology, Oncology and Infectious Diseases, having authored 81 papers that have together received 1.9k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (25 papers), Multiple Myeloma Research and Treatments (19 papers), Cytomegalovirus and herpesvirus research (18 papers), HIV/AIDS drug development and treatment (13 papers), Protein Degradation and Inhibitors (12 papers), Peptidase Inhibition and Analysis (12 papers), HIV Research and Treatment (11 papers) and Toxin Mechanisms and Immunotoxins (7 papers). The work is most often cited by research in Virology (181 citations), Hematology (214 citations), Oncology (472 citations), Epidemiology (588 citations) and Radiology, Nuclear Medicine and Imaging (301 citations). Johan Harmenberg has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Britta Wahrén, Stig Åkerfeldt, Gustav Gilljam, Spotswood L. Spruance, Anna Karlsson, B. Öberg, Lars Franzén, K. Pigott, Dag Clement Johannessen and M. Sokal. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Blood, Antiviral chemistry & chemotherapy, Journal of Clinical Oncology and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact